Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the human host can lead to various clinical manifestations, from symptomless carriers to mild to moderate to severe/critical illness. Therefore, the clinical classification of SARS-CoV-2 disease, based on severity, is a re...

Full description

Bibliographic Details
Main Authors: Nitin Saksena, Srinivasa R. Bonam, Monica Miranda-Saksena, Thyago H. Cardoso
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2022-12-01
Series:Exploration of Immunology
Subjects:
Online Access:https://www.explorationpub.com/Journals/ei/Article/100384
_version_ 1797894841359663104
author Nitin Saksena
Srinivasa R. Bonam
Monica Miranda-Saksena
Thyago H. Cardoso
author_facet Nitin Saksena
Srinivasa R. Bonam
Monica Miranda-Saksena
Thyago H. Cardoso
author_sort Nitin Saksena
collection DOAJ
description The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the human host can lead to various clinical manifestations, from symptomless carriers to mild to moderate to severe/critical illness. Therefore, the clinical classification of SARS-CoV-2 disease, based on severity, is a reliable way to predict disease states in SARS-CoV-2 infection. Recent studies on genomics, transcriptomics, epigenomics, and immunogenomics, along with spatial analysis of immune cells have delineated and defined the categorization of these disease groups using these high throughout technologies. These technologies hold the promise of providing not only a detailed but a holistic view of SARS-CoV-2-led pathogenesis. The main genomic, cellular, and immunologic features of each disease category, and what separates them spatially and molecularly are discussed in this brief review to provide a foundational spatial understanding of SARS-CoV-2 immunopathogenesis.
first_indexed 2024-04-10T07:15:48Z
format Article
id doaj.art-0984e5ecf68d49d8bdbdaf69b522e778
institution Directory Open Access Journal
issn 2768-6655
language English
last_indexed 2024-04-10T07:15:48Z
publishDate 2022-12-01
publisher Open Exploration Publishing Inc.
record_format Article
series Exploration of Immunology
spelling doaj.art-0984e5ecf68d49d8bdbdaf69b522e7782023-02-25T07:28:10ZengOpen Exploration Publishing Inc.Exploration of Immunology2768-66552022-12-012679481110.37349/ei.2022.00084Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 diseaseNitin Saksena0https://orcid.org/0000-0002-2431-9871Srinivasa R. Bonam1https://orcid.org/0000-0002-2888-2418Monica Miranda-Saksena2https://orcid.org/0000-0002-4868-9789Thyago H. Cardoso3https://orcid.org/0000-0002-4620-6579Institute for Health and Sport, Victoria University, Footscray Campus, Melbourne VIC. 3011, Australia; Aegros Therapeutics Pty Ltd, Macquarie Park, Sydney 2019, AustraliaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USAWestmead Institute of Medical Research (WIMR), Herpes Virus Laboratory, Sydney 2145, AustraliaOMICS Centre of Excellence, G42 Healthcare, Mazdar City, Abu Dhabi 3079, United Arab EmiratesThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the human host can lead to various clinical manifestations, from symptomless carriers to mild to moderate to severe/critical illness. Therefore, the clinical classification of SARS-CoV-2 disease, based on severity, is a reliable way to predict disease states in SARS-CoV-2 infection. Recent studies on genomics, transcriptomics, epigenomics, and immunogenomics, along with spatial analysis of immune cells have delineated and defined the categorization of these disease groups using these high throughout technologies. These technologies hold the promise of providing not only a detailed but a holistic view of SARS-CoV-2-led pathogenesis. The main genomic, cellular, and immunologic features of each disease category, and what separates them spatially and molecularly are discussed in this brief review to provide a foundational spatial understanding of SARS-CoV-2 immunopathogenesis.https://www.explorationpub.com/Journals/ei/Article/100384severe acute respiratory syndrome coronavirus-2anti-viral immunitygenomicsinterferonsimmune cellstropism
spellingShingle Nitin Saksena
Srinivasa R. Bonam
Monica Miranda-Saksena
Thyago H. Cardoso
Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease
Exploration of Immunology
severe acute respiratory syndrome coronavirus-2
anti-viral immunity
genomics
interferons
immune cells
tropism
title Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease
title_full Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease
title_fullStr Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease
title_full_unstemmed Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease
title_short Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease
title_sort incursions by severe acute respiratory syndrome coronavirus 2 on the host anti viral immunity during mild moderate and severe coronavirus disease 2019 disease
topic severe acute respiratory syndrome coronavirus-2
anti-viral immunity
genomics
interferons
immune cells
tropism
url https://www.explorationpub.com/Journals/ei/Article/100384
work_keys_str_mv AT nitinsaksena incursionsbysevereacuterespiratorysyndromecoronavirus2onthehostantiviralimmunityduringmildmoderateandseverecoronavirusdisease2019disease
AT srinivasarbonam incursionsbysevereacuterespiratorysyndromecoronavirus2onthehostantiviralimmunityduringmildmoderateandseverecoronavirusdisease2019disease
AT monicamirandasaksena incursionsbysevereacuterespiratorysyndromecoronavirus2onthehostantiviralimmunityduringmildmoderateandseverecoronavirusdisease2019disease
AT thyagohcardoso incursionsbysevereacuterespiratorysyndromecoronavirus2onthehostantiviralimmunityduringmildmoderateandseverecoronavirusdisease2019disease